澳股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

新冠治療股

909.216

-4.061-0.44%

漲家數：10

跌家數：5

平家數：17

市盈率：- -

高：915.545

開：915.545

低：905.057

收：913.277

成交量：1,586.23萬

成交額：1.42億

市值：2,363.53億

流通市值：1,831.21億

資料載入中...

Mesoblast將於下月與FDA會談討論Rexlemestrocel-L和阿片類藥物戒斷

Mesoblast將於下月與FDA會面討論Rexlemestrocel-L和藥物戒斷

CSL LIMITED - CSL Seqirus與疫苗工業公司與衞生部簽署重要諒解備忘錄

Coles Group Ltd - 第二季度初期，超市銷售收入增長保持在與第一季度相似的水平

葛蘭素史克抗癌、抗艾滋病藥物銷售額提升，2025 年前景看好，股價大漲

美國市場動盪不安，澳大利亞 CSL 公司推遲分拆疫苗部門

CSL Ltd - 先前提出的拆分時間推進將無法充分體現Seqirus的價值潛力

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK7501/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK7501","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7501\",,,,,undefined,":{"symbol":"BK7501","market":"AU","secType":"PLATE","nameCN":"新冠治療股","latestPrice":909.2155,"timestamp":1762745474883,"preClose":913.27673,"halted":0,"volume":15862269,"delay":0,"changeRate":-0.004447,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":-4.061218,"latestTime":"11-10 14:31:15 AEDT","open":915.5452,"high":915.5452,"low":905.0574,"amount":141512173,"amplitude":0.011484,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1762750800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1762729200000,1762750800000]],"turnoverRate":0.001103,"increases":10,"decrements":6,"flats":16,"marketCap":236353454736.25,"floatMarketCap":183120960845.58594},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7501\",,,,,undefined,":{"symbol":"BK7501","high":915.5452,"amplitude":0.011484,"preClose":913.27673,"low":905.0574,"latestPrice":909.2155,"volume":15862269,"delay":0,"open":915.5452,"prevYearClose":1117.913,"prevWeekClose":913.277,"prevMonthClose":914.468,"prevQuarterClose":950.171,"fiveDayClose":902.484,"twentyDayClose":972.908,"sixtyDayClose":1133.772,"secType":"PLATE","market":"AU","turnoverRate":0.001103,"marketCap":236353454736.25,"floatMarketCap":183120960845.58594,"timestamp":1762745474883,"nameCN":"新冠治療股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7501\",,,,undefined,":{"bkCode":"BK7501","up":10,"down":5,"flat":17},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7501\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1116191251","title":"Mesoblast將於下月與FDA會談討論Rexlemestrocel-L和阿片類藥物戒斷","url":"https://stock-news.laohu8.com/highlight/detail?id=1116191251","media":"投资观察","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116191251?lang=zh_tw&edition=fundamental","pubTime":"2025-11-05 09:45","pubTimestamp":1762307124,"startTime":"0","endTime":"0","summary":"11月5日（路透社） - Mesoblast Ltd：*MESOBLAST将于下月与FDA会面，讨论Rexlemestrocel-L和阿片类药物戒断* 进一步公司报道：MSB.AX","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","MSB.AU","BK7501","BK7508"],"gpt_icon":0},{"id":"1199521939","title":"Mesoblast將於下月與FDA會面討論Rexlemestrocel-L和藥物戒斷","url":"https://stock-news.laohu8.com/highlight/detail?id=1199521939","media":"美股速递","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199521939?lang=zh_tw&edition=fundamental","pubTime":"2025-11-05 06:59","pubTimestamp":1762297168,"startTime":"0","endTime":"0","summary":"Mesoblast将于下月与FDA会面，讨论Rexlemestrocel-L和药物戒断的相关事宜。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","MESO","BK7501","MSB.AU","BK7067","BK4139"],"gpt_icon":0},{"id":"1185215746","title":"CSL LIMITED - CSL Seqirus與疫苗工業公司與衞生部簽署重要諒解備忘錄","url":"https://stock-news.laohu8.com/highlight/detail?id=1185215746","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185215746?lang=zh_tw&edition=fundamental","pubTime":"2025-10-30 13:55","pubTimestamp":1761803711,"startTime":"0","endTime":"0","summary":"CSL LIMITED - CSL Seqirus与疫苗工业公司与卫生部签署重要谅解备忘录","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","CSL.AU","BK7508","BK7511","BK7501"],"gpt_icon":0},{"id":"1193087172","title":"Coles Group Ltd - 第二季度初期，超市銷售收入增長保持在與第一季度相似的水平","url":"https://stock-news.laohu8.com/highlight/detail?id=1193087172","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193087172?lang=zh_tw&edition=fundamental","pubTime":"2025-10-30 05:29","pubTimestamp":1761773349,"startTime":"0","endTime":"0","summary":"Coles Group Ltd - 第二季度初期，超市销售收入增长保持在与第一季度相似的水平","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7082","COL.AU","BK7040"],"gpt_icon":0},{"id":"2579204689","title":"葛蘭素史克抗癌、抗艾滋病藥物銷售額提升，2025 年前景看好，股價大漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2579204689","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579204689?lang=zh_tw&edition=fundamental","pubTime":"2025-10-29 17:24","pubTimestamp":1761729849,"startTime":"0","endTime":"0","summary":"更新版 1-更新 2-葛兰素史克抗癌、抗艾滋病药物销售额提升，2025 年前景看好，股价大涨股价上涨近 4%，达到 2024 年 5 月以来的最高水平 即将离任的首席执行官沃姆斯利在本季度表现强劲 非美国市场推动疫苗销售增长添加领涨股票、图表和美国疫苗销售详情Bhanvi Satija/Yadarisa Shabong. 美国疫苗销售压力 葛兰素史克表示，在截至9月30日的季度里，公司疫苗销售总额达到26.8亿英镑，高于分析师预测的25.5亿英镑。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nL4T3WA0XE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","LU0225771236.USD","LU1670756490.USD","LU1098665638.USD","GSK.UK","BK5011","LU0971552673.USD","BK7511","IE00BWDBJ516.SGD","LU1035777561.USD","LU1481599808.USD","LU0225284248.USD","LU1481600234.SGD","LU1400636491.USD","BK7501","LU1309081286.SGD","BK7067","LU1487256676.USD","IE00BQJZX424.USD","LU0321505439.SGD","LU1400636574.HKD","LU0971552830.HKD","LU1015430645.USD","LU0211331839.USD","LU1064927863.SGD","LU0109981661.USD","LU0575583348.USD","LU1302929846.USD","CSL.AU","LU0545562505.USD","LU1228905037.USD","LU0289739699.SGD","LU0306806265.USD","LU0203347892.USD","LU0306807586.USD","LU1400636657.SGD","LU0321505868.SGD","LU0985481810.HKD","IE0034235071.USD","LU1046248800.SGD","LU1202635105.USD","LU0161305163.EUR","BK7508","LU1645745479.HKD","LU1228905540.USD","LU0203345920.USD"],"gpt_icon":0},{"id":"2578740406","title":"美國市場動盪不安，澳大利亞 CSL 公司推遲分拆疫苗部門","url":"https://stock-news.laohu8.com/highlight/detail?id=2578740406","media":"路透中文","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578740406?lang=zh_tw&edition=fundamental","pubTime":"2025-10-28 06:23","pubTimestamp":1761603803,"startTime":"0","endTime":"0","summary":"美国市场动荡不安，澳大利亚 CSL 公司推迟分拆疫苗部门路透10月27日 - 澳大利亚生物技术公司CSL CSL.AX周二表示，由于美国流感疫苗市场波动加剧，该公司不再以在2026财年完成疫苗部门的分拆为目标。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251027:nL4S3W81OY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","BK7067","BK7501","BK7508","CSL.AU"],"gpt_icon":0},{"id":"1194146757","title":"CSL Ltd - 先前提出的拆分時間推進將無法充分體現Seqirus的價值潛力","url":"https://stock-news.laohu8.com/highlight/detail?id=1194146757","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194146757?lang=zh_tw&edition=fundamental","pubTime":"2025-10-28 06:12","pubTimestamp":1761603128,"startTime":"0","endTime":"0","summary":"CSL Ltd - 先前提出的拆分时间推进将无法充分体现Seqirus的价值潜力","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSL.AU","BK7508","BK7501","BK7067","BK7511"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":7,"code":"91000000","status":"200"}]}}